{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T22:00:35Z","timestamp":1648504835361},"reference-count":13,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1179\/joc.2005.17.1.111","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T18:05:31Z","timestamp":1389290731000},"page":"111-114","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of a Gilbert's Syndrome Patient with Irinotecan, Leucovorin and 5-Fluorouracil"],"prefix":"10.1080","volume":"17","author":[{"given":"Y.","family":"Komatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Yuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuse","family":"Fuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Asaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,7,18]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","unstructured":"Iyer L, King CD, Whitington PF et al. Genetic predispo-sition to the metabolism of irinotecan (CPT-11). Role of uri-dine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. J Clin Invest 1998; 101 (4): 847-854.","DOI":"10.1172\/JCI915"},{"issue":"14","key":"CIT0002","first-page":"3723","volume":"54","author":"Gupta E","year":"1994","journal-title":"Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea. Cancer Res"},{"key":"CIT0005","first-page":"1382","volume":"22","author":"Innocenti F","year":"2004","journal-title":"Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol"},{"key":"CIT0006","first-page":"501","volume":"75","author":"Sai K","year":"2004","journal-title":"UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with can-cer. Clin Pharmacol Ther"},{"key":"CIT0007","unstructured":"Komatsu Y, Takei M, Kato T et al. Phase VII study of irinotecan (irinotecan) combined with 1-leucovorin (l-LV) and 5FU in patients with advanced colorectal cancer. The 18th UICC International Cancer Congress Abstract: 962"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1586\/14737159.2.5.487"},{"key":"CIT0009","first-page":"46","volume":"29","author":"Mort A","year":"2003","journal-title":"Med Sci Digest"},{"key":"CIT0010","first-page":"21","volume":"46","author":"Akaba K","year":"1998","journal-title":"Neonatal hyper-bilirubinemia and mutation of the bilirubin uridine diphos-phate-glucuronosyltransferase gene. Biochem Mol Biol Int"},{"key":"CIT0011","first-page":"1224","volume":"103","author":"Maruo Y","year":"1999","journal-title":"Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyl-transferase polymorphism. Pediatrics"},{"key":"CIT0012","first-page":"905","volume":"28","author":"Saltz LB","year":"2000","journal-title":"Irinotecan plus fluo-rouracil and leucovorin for metastatic colorectal cancer. N Engl J Med"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02034-1"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1996.tb26399.x"},{"key":"CIT0015","first-page":"6921","volume":"60","author":"Ando Y","year":"2000","journal-title":"Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res"}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10256018808623883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T05:42:09Z","timestamp":1498110129000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1179\/joc.2005.17.1.111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,7,18]]},"published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1179\/joc.2005.17.1.111"],"URL":"https:\/\/doi.org\/10.1179\/joc.2005.17.1.111","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"value":"1120-009X","type":"print"},{"value":"1973-9478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}